Yaws
MONDO:0006019An endemic, infectious, nonvenereal disease in humans that presents mainly in children younger than 15 years. The disease occurs primarily in warm, humid, tropical areas of Africa, Asia, South America, and Oceania, among poor rural populations where conditions of overcrowding and poor sanitation prevail. Infection with Treponema pertenue, a subspecies of Treponema pallidum, causes the disease.
Also known as: Bouba, Treponema pallidum subsp. pertenue caused disease or disorder, Treponema pallidum subsp. pertenue disease or disorder, Treponema pallidum subsp. pertenue infectious disease, frambesia, frambesia tropica, Treponema pertenue infection, endemic treponematoses
13 clinical trials for this condition and its sub-types, 3 tagged with Yaws itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Yaws
-
Early yaws 1 trial
-
Late yaws 0 trials
-
Latent yaws 0 trials
-
Tertiary lesion of yaws 0 trials
-
New antibiotic cocktail aimed at Drug-Resistant infections in babies
Disease control Recruiting nowThis study tests a combination of two antibiotics, aztreonam and avibactam, in newborns and infants up to 9 months old who have serious infections caused by gram-negative bacteria. The trial has two parts: one to see how a single dose moves through the body, and another to test m…
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Laser breakthrough? new trial aims to save sight in diabetic patients
Disease control Recruiting nowThis study tests a micropulse laser for diabetic macular edema, a condition causing vision loss in people with diabetes. Fifty participants with initial or stubborn swelling will receive the laser treatment. Researchers will measure changes in vision and retinal thickness to see …
Sponsor: The General Authority for Teaching Hospitals and Institutes • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Double antibiotic attack: could a Two-Drug combo beat severe infections faster?
Disease control Recruiting nowThis study tests whether adding a second antibiotic (fosfomycin) to the standard antibiotic (ceftazidime) helps people with severe gram-negative infections recover faster. About 100 hospitalized adults will be randomly assigned to get either the combo or the standard drug plus a …
Phase 3 • Sponsor: Angela HUTTNER • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Real-World watch: is zavicefta safe for tough infections?
Knowledge-focused Recruiting nowThis study observes 600 patients in Korea who receive Zavicefta for complicated abdominal or urinary tract infections or hospital-acquired pneumonia. Researchers track side effects and how well the drug works. It is required by Korean regulators to ensure the drug's safety after …
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC